CA
NZ
UK
AU
IND
US
Hims & Hers Health (NYSE:HIMS) shares were trading at $30.75 in pre-market activity on August 12, 2026, up 0.79% from the prior close of $30.51. The move follows Tuesday's roughly 4% post-earnings decline, as investors weighed a mix of strong top-line growth against notable …
Johnson & Johnson (NYSE:JNJ) shares were trading at $258.61 in pre-market activity on August 12, 2026, down 0.46% from the prior close of $259.80. The pullback follows a strong multi-week run that had pushed the stock near its 52-week high of $274.90 and to …
AbCellera (NASDAQ:ABCL) shares were trading at $8.91 in pre-market activity on August 12, 2026, down 8.71% from the prior close of $9.76. The decline follows the company's announcement of a $200 million underwritten public offering of common shares and pre-funded warrants, disclosed after the …
Absci (NASDAQ:ABSI) shares were trading at $8.70 in pre-market activity on August 12, 2026, down 7.55% from the prior close of $9.41. Shares had gained 4.44% during the prior regular session, but slid in extended and pre-market trading as investors weighed the company's second …
Liquidia (NASDAQ:LQDA) shares were trading at $91.91 in pre-market activity on August 12, 2026, up 4.38% from the prior close of $88.05. The move comes ahead of the company's second quarter fiscal 2026 earnings report, scheduled for release before market open the same day.
Wave Life Sciences (NASDAQ:WVE) shares were trading at $5.38 in pre-market activity on August 12, 2026, up 6.64% from the prior close of $5.05. The move follows a prior-session slide to a fresh 52-week low near $5.01, with shares having fallen roughly 25% over …
Zura Bio (NASDAQ:ZURA) shares were trading at $5.79 in pre-market activity on August 12, 2026, up 4.14% from the prior close of $5.56. The prior session's close had come in slightly lower, down 1.24%, even as the company reported second quarter 2026 results and …
Cigna (NYSE:CI) shares are trading down 2.17% intraday to $272.36, from a prior close of $278.40. The decline comes as billionaire investor Mark Cuban publicly urged shareholders to pressure major insurers, including Cigna, UnitedHealth (NYSE:UNH), CVS (NYSE:CVS), Elevance (NYSE:ELV), Humana (NYSE:HUM), and Centene (NYSE:CNC), …
Elevance Health (NYSE:ELV) shares are trading down 2.00% intraday to $389.73, from a prior close of $397.70. The decline comes as billionaire investor Mark Cuban publicly urged shareholders to pressure insurers, including Elevance, UnitedHealth (NYSE:UNH), CVS (NYSE:CVS), Cigna (NYSE:CI), Humana (NYSE:HUM), and Centene (NYSE:CNC), …
GeneDx Holdings (NASDAQ:WGS) shares are trading up 6.05% intraday to $82.59, from a prior close of $77.88. The move follows the company's announcement of a new online offering designed to expand accessibility of exome testing at scale for pediatric patients with global developmental delay, …
Please wait processing your request...